Veracyte Inc VCYT:NASDAQ

Last Price$26.50NASDAQ Previous Close - Last Trade as of 4:00PM ET 9/20/19
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$26.51 (1)
Ask (Size)$26.51 (2)
Day Low / HighN/A - N/A
Volume1.1 M

Veracyte Posts Narrower Q2 Loss vs Estimate, Revenue Narrowly Beats Forecast; Lifts FY2019 Revenue Outlook

6:39AM ET 7/31/2019 MT Newswires
Veracyte (VCYT) reported late Tuesday Q2 net loss of $0.05 per share compared to a net loss of $0.18 per share in the year-ago period. Wall Street analysts were expecting a net loss of $0.08 per share for the June quarter.

The genomic diagnostics company saw revenue rise to $30.14 million from $22.8 million in the comparable quarter a year ago. The result also topped analysts' average estimate of $29.16 million.

Moving forward, Veracyte said it is raising its 2019 annual revenue guidance to a range of $119 million to $122 million from its previous forecast of $117 million to $121 million. Forecasts are for sales of $120.54 million.

Price: 29.61, Change: +0.43, Percent Change: +1.47